Eli Lilly Kicks Off High-Grade Bond Sale in Push to Fund Deals

Eli Lilly's decision to enter the bond market highlights the company's aggressive approach towards growth through acquisitions. By leveraging debt financing, Lilly can capitalize on strategic opportunities while maintaining liquidity. This strategy may also signal to investors that the company is poised for expansion, although it raises questions about the long-term implications of increased leverage.